<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The metabolic or <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome, characterized by <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> and <z:hpo ids='HP_0000842'>hyperinsulinemia</z:hpo>, may have genetic determinants </plain></SENT>
<SENT sid="1" pm="."><plain>The insulin gene (INS), insulin receptor gene (INSR) and insulin receptor substrate 1 gene (IRS1) have been proposed as candidate genes </plain></SENT>
<SENT sid="2" pm="."><plain>We examined eight polymorphisms in these genes in 163 individuals from Yucatan, Mexico; this population has a high prevalence of <z:hpo ids='HP_0001513'>obesity</z:hpo>, type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Subjects were evaluated for body mass index (BMI) and blood pressure </plain></SENT>
<SENT sid="4" pm="."><plain>Blood samples were collected to determine <z:chebi fb="105" ids="17234">glucose</z:chebi>, insulin, <z:chebi fb="4" ids="17855">triglycerides</z:chebi> and cholesterol levels, as well as for DNA isolation </plain></SENT>
<SENT sid="5" pm="."><plain>Restriction fragment length polymorphisms in INS, INSR and IRS1 were identified by polymerase chain reaction and digestion with selected restriction enzymes </plain></SENT>
<SENT sid="6" pm="."><plain>Among the eight polymorphisms analyzed, the PstI polymorphism in INS was significantly associated with <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> and with the presence of at least one abnormality related to the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (P=0.007 and 0.004, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>The MaeIII polymorphism in INS was associated with <z:hpo ids='HP_0008283'>fasting hyperinsulinemia</z:hpo> (P=0.045) </plain></SENT>
<SENT sid="8" pm="."><plain>In multilocus analyses including both INS polymorphisms, significant associations were seen with <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> (P=0.006), <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> (P=0.031) and with presence of at least one metabolic abnormality (P=0.009) </plain></SENT>
<SENT sid="9" pm="."><plain>None of the polymorphisms in INSR or IRS1 was associated with any of these traits </plain></SENT>
<SENT sid="10" pm="."><plain>These findings suggest that the insulin gene may be an important determinant of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, and particularly of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, in this population </plain></SENT>
</text></document>